Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG

Walter, Roland B; Othus, Megan; Löwenberg, Bob; Ossenkoppele, Gert J; Petersdorf, Stephen H; Pabst, Thomas; Vekemans, Marie-Christiane; Appelbaum, Frederick R; Erba, Harry P; Estey, Elihu H (2015). Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOG. Haematologica - the hematology journal, 100(10), e409-e411. Ferrata-Storti Foundation 10.3324/haematol.2015.130013

Full text not available from this repository.

Item Type:	Journal Article (Further Contribution)
Division/Institute:	04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology
UniBE Contributor:	Pabst, Thomas Niklaus
Subjects:	600 Technology > 610 Medicine & health
ISSN:	0390-6078
Publisher:	Ferrata-Storti Foundation
Language:	English
Submitter:	Marianne Zahn
Date Deposited:	17 Mar 2016 14:46
Last Modified:	02 Mar 2023 23:27
Publisher DOI:	10.3324/haematol.2015.130013
PubMed ID:	26160876
Uncontrolled Keywords:	acute myeloid leukemia clinical trials eligibility criteria refractory relapsed
URI:	https://boris.unibe.ch/id/eprint/77198